Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss the impact of a single or two-dose regimen of inclisiran on time averaged reductions in LDL-C (ORION 1); achieving very low LDL-C levels with evolocumab (FOURIER); renal denervation in the absence of antihypertensive medication (SPYRAL HTN-OFF MED).

Keywords: ESC2017, ESC Congress

< Back to Listings